Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-24 Sale | 2023-02-27 6:08 pm | Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle CEO and President | 10,385 | $0.1274 | $1,323 | 0 (Direct) | View |
| 2023-02-01 Sale | 2023-02-01 9:41 pm | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J Director | 8,448 | $0.25 | $2,112 | 66,082 (Direct) | View |
| 2023-02-01 Sale | 2023-02-01 9:40 pm | Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle CEO and President | 3,878 | $0.25 | $970 | 32,885 (Direct) | View |
| 2023-01-31 Sale | 2023-01-31 9:51 pm | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J Director | 7,240 | $0.241 | $1,745 | 192,030 (Direct) | View |
| 2023-01-31 Sale | 2023-01-31 9:50 pm | Rubius Therapeutics Inc. | RUBY | Turka Laurence A. Chief Scientific Officer | 2,593 | $0.24 | $622 | 59,140 (Direct) | View |
| 2022-08-10 Sale | 2022-08-12 3:06 pm | Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle Chief Operating Officer | 5,737 | $0.8 | $4,590 | 44,263 (Direct) | View |
| 2022-04-21 Purchase | 2022-04-22 6:07 pm | Rubius Therapeutics Inc. | RUBY | Epstein David R Director | 30,000 | $1.4443 | $43,329 | 4,720,012 (Direct) | View |
| 2022-02-01 Sale | 2022-02-01 9:20 pm | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President | 6,730 | $6.573 | $44,236 | 564,270 (Direct) | View |
| 2022-02-01 Sale | 2022-02-01 9:19 pm | Rubius Therapeutics Inc. | RUBY | Keson-Brookes Maiken CLO & Corp. Secretary | 2,732 | $6.573 | $17,957 | 207,818 (Direct) | View |
| 2022-02-01 Sale | 2022-02-01 9:18 pm | Rubius Therapeutics Inc. | RUBY | Turka Laurence A. Chief Scientific Officer | 2,517 | $6.573 | $16,544 | 205,483 (Direct) | View |
| 2021-03-19 Purchase | 2021-03-23 5:30 pm | Rubius Therapeutics Inc. | RUBY | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner | 210,000 | $29 | $6,090,000 | 17,253,519 (Indirect) | View |
| 2021-03-15 Sale | 2021-03-15 8:28 pm | Rubius Therapeutics Inc. | RUBY | Keson-Brookes Maiken CLO & Corp. Secretary | 25,000 | $20.24 | $505,965 | 225,000 (Direct) | View |
| 2021-02-11 Sale | 2021-02-16 9:51 pm | Rubius Therapeutics Inc. | RUBY | Epstein David R Director | 26,704 | $14.93 | $398,560 | 4,690,012 (Direct) | View |
| 2021-02-08 Sale | 2021-02-10 9:12 pm | Rubius Therapeutics Inc. | RUBY | Epstein David R Director | 98,737 | $14.88 | $1,468,788 | 4,716,716 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-31 Exercise | 2023-02-01 9:40 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle CEO and President | 7,500 | $0 | 32,885 (Direct) | View |
| 2023-01-29 Exercise | 2023-01-31 9:51 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J Director | 46,250 | $0 | 192,030 (Direct) | View |
| 2023-01-29 Exercise | 2023-01-31 9:50 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | Turka Laurence A. Chief Scientific Officer | 16,063 | $0 | 59,140 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-12 3:06 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle Chief Operating Officer | 12,500 | $0 | 44,263 (Direct) | View |
| 2022-07-29 Option Award | 2022-08-01 5:38 pm | N/A 2032-07-28 | Rubius Therapeutics Inc. | RUBY | Schaffert Susanne Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-13 4:35 pm | N/A 2032-05-11 | Rubius Therapeutics Inc. | RUBY | Prener Anne Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-13 4:33 pm | N/A 2032-05-11 | Rubius Therapeutics Inc. | RUBY | Holles Natalie C. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-13 4:31 pm | N/A 2032-05-11 | Rubius Therapeutics Inc. | RUBY | Cuss Francis M Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-13 4:28 pm | N/A 2032-05-11 | Rubius Therapeutics Inc. | RUBY | Rosenblatt Michael Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-13 4:26 pm | N/A 2032-05-11 | Rubius Therapeutics Inc. | RUBY | Sohn Catherine A. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-13 4:24 pm | N/A 2032-05-11 | Rubius Therapeutics Inc. | RUBY | AFEYAN NOUBAR Director 10% Owner | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-13 4:22 pm | N/A 2032-05-11 | Rubius Therapeutics Inc. | RUBY | Symonds Jonathan Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-13 4:20 pm | N/A 2032-05-11 | Rubius Therapeutics Inc. | RUBY | Epstein David R Director | 499,762 | $0 | 499,762 (Direct) | View |
| 2021-04-26 Ownership | 2022-02-14 7:52 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President | 6,200 | $0 | 29,320 (Direct) | View |
| 2022-01-29 Exercise | 2022-02-01 9:20 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President | 21,250 | $0 | 564,270 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 9:20 pm | N/A 2032-01-30 | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President | 465,000 | $0 | 564,270 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 9:20 pm | N/A 2032-01-30 | Rubius Therapeutics Inc. | RUBY | Carmona Jose Chief Financial Officer | 178,250 | $0 | 178,250 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 9:19 pm | N/A 2032-01-30 | Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle Chief Operating Officer | 155,000 | $0 | 155,000 (Direct) | View |
| 2022-01-29 Exercise | 2022-02-01 9:19 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | Keson-Brookes Maiken CLO & Corp. Secretary | 8,075 | $0 | 207,818 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 9:19 pm | N/A 2032-01-30 | Rubius Therapeutics Inc. | RUBY | Keson-Brookes Maiken CLO & Corp. Secretary | 178,250 | $0 | 207,818 (Direct) | View |
| 2022-01-29 Exercise | 2022-02-01 9:18 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | Turka Laurence A. Chief Scientific Officer | 7,438 | $0 | 205,483 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 9:18 pm | N/A 2032-01-30 | Rubius Therapeutics Inc. | RUBY | Turka Laurence A. Chief Scientific Officer | 178,250 | $0 | 205,483 (Direct) | View |
| 2021-08-31 Option Award | 2021-09-01 8:12 pm | N/A 2031-08-30 | Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle Chief Operating Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-13 8:35 pm | N/A 2031-05-11 | Rubius Therapeutics Inc. | RUBY | Epstein David R Director | 27,919 | $0 | 27,919 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-13 8:35 pm | N/A 2031-05-11 | Rubius Therapeutics Inc. | RUBY | Symonds Jonathan Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-13 8:35 pm | N/A 2031-05-11 | Rubius Therapeutics Inc. | RUBY | AFEYAN NOUBAR Director 10% Owner | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-13 8:35 pm | N/A 2031-05-11 | Rubius Therapeutics Inc. | RUBY | Sohn Catherine A. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-13 8:35 pm | N/A 2031-05-11 | Rubius Therapeutics Inc. | RUBY | Rosenblatt Michael Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-13 8:34 pm | N/A 2031-05-11 | Rubius Therapeutics Inc. | RUBY | Cuss Francis M Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-13 8:34 pm | N/A 2031-05-11 | Rubius Therapeutics Inc. | RUBY | Holles Natalie C. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-13 8:34 pm | N/A 2031-05-11 | Rubius Therapeutics Inc. | RUBY | Prener Anne Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-15 8:28 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | Keson-Brookes Maiken CLO & Corp. Secretary | 25,000 | $7.7 | 225,000 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-15 8:28 pm | N/A 2029-11-28 | Rubius Therapeutics Inc. | RUBY | Keson-Brookes Maiken CLO & Corp. Secretary | 25,000 | $0 | 225,000 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 8:27 pm | N/A 2031-01-28 | Rubius Therapeutics Inc. | RUBY | Keson-Brookes Maiken CLO & Corp. Secretary | 174,800 | $0 | 174,800 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 8:27 pm | N/A 2031-01-28 | Rubius Therapeutics Inc. | RUBY | Coughlin Christina M. Chief Medical Officer | 174,800 | $0 | 174,800 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 8:27 pm | N/A 2031-01-28 | Rubius Therapeutics Inc. | RUBY | Turka Laurence A. Chief Scientific Officer | 161,000 | $0 | 161,000 (Direct) | View |